News about Drug Discovery & Development

Acumen Pharmaceuticals Appoints New Chief Regulatory Officer and Head of Quality

Dr. Schacterle brings over 30 years of experience in regulatory affairs, quality assurance, and therapeutic development to Acumen, with a focus on diseases of the central nervous system.

Drug Discovery & Development | 07/11/2024 | By Aishwarya |  666

Duoning Biotech and Branca Bunus to Develop Transfection Reagents

Under this agreement, the two companies will collaborate on the development, optimization, and application of transfection reagents, with the goal of providing biopharmaceutical customers with innovative transfection reagents through resource sharing, thereby enhancing the efficiency of biopharmaceutical development in upstream bioprocess.

Drug Discovery & Development | 07/11/2024 | By Aishwarya |  393

Syndax Signs USD 350 Million Royalty Funding Deal with Royalty Pharma for Niktimvo

Under the terms of the agreement, Syndax received an upfront payment of USD 350 million in exchange for a 13.8 percent royalty on US net sales of Niktimvo.

Drug Discovery & Development | 06/11/2024 | By Aishwarya |  710

Formosa Pharma Signs Licensing Deal with DAVI for Clobetasol Propionate Ophthalmic Suspension

The DÁVI licensing agreement includes upfront, commercialization milestones, and sales milestones, with additional considerations throughout the term of the agreement.

Drug Discovery & Development | 04/11/2024 | By Aishwarya |  716

AbbVie and EvolveImmune to Develop Next-Gen Cancer Biotherapeutics

EvolveImmune's proprietary EVOLVE platform is designed to deliver potent, selective and integrated T-cell co-stimulation to amplify and sustain the tumor killing capacity of the T-cells.

Drug Discovery & Development | 01/11/2024 | By Aishwarya |  432

GC Biopharma Partners with Novelty Nobility to Jointly Research for Geographic Atrophy Therapies

Under the terms of the agreement, GC Biopharma and Novelty Nobility established a partnership to jointly research and develop antibody-based protein therapeutics for GA throughout all stages of the drug development lifecycle.

Drug Discovery & Development | 28/10/2024 | By Aishwarya |  301

Viatris Signs Licensing Deal with Lexicon Pharmaceuticals for Sotagliflozin

This licensing agreement leverages Viatris' expertise in cardiovascular diseases and its Global Healthcare Gateway, which offers partners ready access to more markets and patients worldwide through the company's unique global infrastructure and expertise.

Drug Discovery & Development | 18/10/2024 | By Aishwarya |  715

Kvantify Launches New Computational Method for Drug Discovery

The method stands out significantly from other solutions on the market and is a strong addition to Kvantify's computational drug discovery platform, Koffee.

Drug Discovery & Development | 14/10/2024 | By Aishwarya |  402

Lipocine Signs Supply and Distribution Deal with Pharmalink to Commercialize TLANDO

Under the terms of the agreement, Lipocine received an upfront payment from Pharmalink and, upon Marketing Authorizations (MA) in individual GCC countries, Lipocine will provide TLANDO drug products to Pharmalink at an agreed transfer price.

Drug Discovery & Development | 11/10/2024 | By Aishwarya |  282

Alkem Laboratories Signs Licensing Deal with Sonnet BioTherapeutics

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet and enable global and India regulatory filings.

Drug Discovery & Development | 10/10/2024 | By Aishwarya |  513